A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19

Clinical Trial to "Study the Efficacy and Therapeutic Safety of Ivermectin: (SAINTBO)

NCT04836299 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Brilacidin in Hospitalized Participants With COVID-19

NCT04784897 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Trimodulin in Subjects With Severe COVID-19

NCT04576728 ·Status: COMPLETED ·Phase: PHASE2

Pegylated Interferon Lambda Treatment for COVID-19

NCT04343976 ·Status: TERMINATED ·Phase: PHASE2

Study for Efficacy and Safety Assessment of the Drug RADAMIN®VIRO for COVID-19 Postexposure Prophylaxis

NCT05722691 ·Status: COMPLETED ·Phase: PHASE3

Intravenous Zotatifin in Adults With Mild or Moderate COVID-19

NCT04632381 ·Status: COMPLETED ·Phase: PHASE1

Study of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in Adults

NCT04417257 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacodynamics for the Treatment of COVID-19.

NCT04847544 ·Status: COMPLETED ·Phase: PHASE2

MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780463 ·Status: COMPLETED ·Phase: PHASE3

Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections

NCT04365725 ·Status: COMPLETED

Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection

NCT04244084 ·Status: COMPLETED ·Phase: PHASE3

Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation

NCT04539262 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of S-892216 in Participants With COVID-19

NCT06928051 ·Status: COMPLETED ·Phase: PHASE2

Piclidenoson for Treatment of COVID-19

NCT04333472 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19

NCT03891420 ·Status: TERMINATED ·Phase: PHASE1

A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults

NCT04464460 ·Status: WITHDRAWN ·Phase: PHASE1

Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019

NCT04310228 ·Status: UNKNOWN ·Phase: NA

Study of the Safety of Therapeutic Treatment With an Immunomodulatory Agent (N-803) in Adults With COVID-19

NCT04385849 ·Status: TERMINATED ·Phase: PHASE1

COVID-19 and Anti-CD14 Treatment Trial

NCT04391309 ·Status: TERMINATED ·Phase: PHASE2

MP1032 Treatment in Patients With Moderate to Severe COVID-19

NCT04932941 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)

NCT04439071 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Ivermectin In Treatment of COVID 19 Patients

NCT04425707 ·Status: UNKNOWN ·Phase: NA

A Trial of Remdesivir in Adults With Severe COVID-19

NCT04257656 ·Status: TERMINATED ·Phase: PHASE3

Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients

NCT04321993 ·Status: UNKNOWN ·Phase: PHASE2

Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections

NCT06379542 ·Status: RECRUITING ·Phase: PHASE3